Differential Responses to Psychotherapy versus Pharmacotherapy in Patients with Chronic Forms of Major Depression and Childhood Trauma
Major depressive disorder is associated with considerable morbidity, disability, and risk for suicide. Treatments for depression most commonly include antidepressants, psychotherapy, or the combination. Little is known about predictors of treatment response for depression. In this study, 681 patient...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 100; no. 24; pp. 14293 - 14296 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
25.11.2003
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Major depressive disorder is associated with considerable morbidity, disability, and risk for suicide. Treatments for depression most commonly include antidepressants, psychotherapy, or the combination. Little is known about predictors of treatment response for depression. In this study, 681 patients with chronic forms of major depression were treated with an antidepressant (nefazodone), Cognitive Behavioral Analysis System of Psychotherapy (CBASP), or the combination. Overall, the effects of the antidepressant alone and psychotherapy alone were equal and significantly less effective than combination treatment. Among those with a history of early childhood trauma (loss of parents at an early age, physical or sexual abuse, or neglect), psychotherapy alone was superior to antidepressant monotherapy. Moreover, the combination of psychotherapy and pharmacotherapy was only marginally superior to psychotherapy alone among the childhood abuse cohort. Our results suggest that psychotherapy may be an essential element in the treatment of patients with chronic forms of major depression and a history of childhood trauma. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 To whom correspondence should be addressed at: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, WMB, Suite 4000, Atlanta, GA 30322. E-mail: cnemero@emory.edu. Abbreviations: CBASP, Cognitive Behavioral Analysis System of Psychotherapy; MDD, major depressive disorder; HRSD24, 24-item Hamilton Rating Scale for Depression; LOCF, Last Observation Carried Forward. C.B.N., C.M.H., M.E.T., A.J.R., A.F.S., P.T.N., D.L.D., B.O.R., S.K., G.K., and M.B.K. consult, receive research support, and/or are on the speaker bureau for Bristol-Myers-Squibb. Communicated by Wylie Vale, The Salk Institute for Biological Studies, La Jolla, CA, September 23, 2003 |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.2336126100 |